QC
AMGN icon

Quantessence Capital’s Amgen AMGN Stock Holding History

Quantessence Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,257
Closed -$2.05M – 25
2025
Q3 		$2.05M Buy
+7,257
New +$2.1M 0.65% 49
2025
Q2 		– Sell
-12,463
Closed -$3.88M – 196
2025
Q1 		$3.88M Buy
+12,463
New +$3.68M 0.97% 17

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Quantessence Capital's AMGN Position: Q4 2025 in Review

Quantessence Capital sold out of Amgen (AMGN) in Q4 2025, closing a stake of 7,257 shares — an estimated $2.05M sold.

Quantessence Capital first reported a position in AMGN in Q1 2025 and held it in 2 quarters. The position peaked at $3.88M in Q1 2025. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Quantessence Capital reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Quantessence Capital sold 7,257 Amgen shares in Q4 2025, an estimated $2.05M.
  • Quantessence Capital first reported a position in Amgen in Q1 2025 and held it in 2 quarters.
  • Quantessence Capital's Amgen position peaked at $3.88M in Q1 2025.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.